Virtual reality-based exercise in elderly people, people with Alzheimer's disease and people with schizophrenia

Not Applicable

• Conditions: eurodegenerative and mental disorders, Alzheimer's disease, schizophrenia; Mental and Behavioural Disorders

• Registration Number: ISRCTN85177142
• Lead Sponsor: Akademii Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-03-14
• Last Update Posted: 27 March 2023
• Study Completion: 2025-12-31

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 180

Inclusion Criteria

Clinical trial no. 1
1.1. Women and men aged = 60,
1.2. Written consent to participate in the study,
1.3. The ability to understand and follow the therapist's instructions,
1.4. Everyday functional efficiency assessed on the Barthel index above 20 points,
1.5. Cognitive efficiency assessed using the mini-mental state examination test, at the level of 26 - 30 points.

Clinical trial no. 2
2.1. Women and men aged = 60,
2.2. I or II stage of Alzheimer's disease,
2.3. Written consent from the participant or his legal health care provider to participate in the study,
2.4. The ability to understand and follow the therapist's instructions,
2.5. Everyday functional efficiency assessed on the Barthel index above 20 points,
2.6. Cognitive efficiency assessed using the mini-mental state examination test at the level of 11 - 24 points.

Clinical trial no. 3
3.1. Women and men aged = 18,
3.2. Clinically confirmed schizophrenia for at least 5 years, with predominance of negative symptoms,
3.3. Unchanged pharmacotherapy for at least 3 months,
3.4. Written consent from the patient or his legal medical provider to participate in the study,
3.5. The ability to understand and follow the therapist's instructions,
3.6. Everyday functional efficiency assessed on the Barthel index above 20 points,
3.7. Cognitive efficiency assessed using the mini-mental state examination test at the level of 19 - 24 points.

Exclusion Criteria

Clinical trial no. 1
1.1. Contraindications to the exercises applied in the study,
1.2. Neurodegenerative and mental diseases,
1.3. Diseases of the nervous system (neuropathy, stroke, damage to the cerebellum, inner ear and labyrinth of the ear, Parkinson's disease),
1.4. Illnesses and diseases of the musculoskeletal system that disturb the balance of the body and the mobility of the limbs.

Clinical trial no. 2
2.1. Contraindications to the exercises applied in the study,
2.2. III stage of Alzheimer's disease;
2.3. Diseases of the nervous system (neuropathy, stroke, damage to the cerebellum, inner ear and labyrinth of the ear, parkinson's disease and others affecting functional efficiency and posture control),
2.4. Illnesses and diseases of the musculoskeletal system that disturb the balance of the body and the mobility of the limbs.

Clinical trial no. 3
3.1. Contraindications to the exercises applied in the study,
3.2. Diseases of the nervous system and sense organs (neuropathy, stroke, damage to the cerebellum, inner ear and labyrinth of the ear, parkinson's disease and others affecting functional efficiency),
3.3. Illnesses and diseases of the musculoskeletal system that impair functional efficiency.

Study & Design

• Study Type: Interventional
• Study Design: Not specified